# Bumetanide

NDC: 0832-0540
Generic name: BUMETANIDE
Labeler / Manufacturer: Upsher-Smith Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20180130
Marketing ended: 20260930
FDA application: ANDA209916

## Active ingredients

- BUMETANIDE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0832-0540"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0832-0540
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff5dc8c6-b2f2-41d3-8e56-a953aa721b59